Non-obese diabetic (NOD) mice, a model of insulin-dependent diabetes mellitus, have a defect in natural killer (NK) cell-mediated functions. Here we show impairment in an activating receptor, NKG2D, in NOD NK cells. While resting NK cells from C57BL/6 and NOD mice expressed equivalent levels of NKG2D, upon activation NOD NK cells, but not C57BL/6 NK cells, expressed NKG2D ligands, which resulted in down-modulation of the receptor. NKG2D-dependent cytotoxicity and cytokine production were decreased because of receptor modulation, accounting for the dysfunction. Modulation of NKG2D was mostly dependent on the YxxM motif of DAP10, the NKG2D-associated adapter that activates phosphoinositide 3 kinase. These results suggest that NK cells may be desensitized by exposure to NKG2D ligands.
Introduction
Insulin-dependent diabetes mellitus (IDDM) is a multi-factorial autoimmune disease characterized by the destruction of insulin-producing β cells by auto-reactive T lymphocytes in the pancreas (Bach, 1994; Castano and Eisenbarth, 1990 ). Accompanying T cell dependent autoimmune responses, IDDM patients and non-obese diabetic (NOD) mice demonstrate impaired immune responses against certain pathogens (Attallah et al., 1987; Cameron et al., 1998; Kataoka et al., 1983) . In addition, several reports suggest that natural killer (NK) cell-mediated functions may be abnormal in IDDM patients and NOD mice (Carnaud et al., 2001; Kataoka et al., 1983; Nair et al., 1986; Negishi et al., 1986; Poulton et al., 2001) . Indeed, cytotoxicity of NK cells from NOD mice and certain IDDM patients against NK-sensitive tumor cell targets (e.g. K562 and YAC-1) is lower than that observed when using NK cells from normal, healthy mice or humans (Carnaud et al., 2001; Kataoka et al., 1983; Nair et al., 1986; Negishi et al., 1986; Poulton et al., 2001) . However, the molecular mechanisms underlying the NK cell abnormalities in IDDM patients and NOD mice are not defined.
NK cells play important roles in immune defense against viral, bacterial and parasitic infections by killing infected cells directly and producing inflammatory cytokines, such as interferon (IFN) -γ and tumor necrosis factor (TNF) -α (Biron et al., 1999; Trinchieri, 1989) . To accomplish these functions, NK cells recognize target cells through a diverse array of activating receptors (Lanier, 1998) . One of the activating receptors, NKG2D (Bauer et al., 1999) , is a co-stimulatory receptor expressed on NK cells, NKT cells, CD8 + T cells, γδ T cells and activated macrophages. NKG2D is associated with a transmembrane adapter molecule, DAP10, which has a YxxM motif that recruits the p85 phoshoinositide-3 (PI3) kinase subunit (Wu et al., 1999) . Therefore, NKG2D-dependent activation utilizes the PI3 kinase pathway. Recent studies revealed that cytotoxicity of 3 mouse NK cells against YAC-1 mainly depends on NKG2D (Jamieson et al., 2002) .
Genomic linkage analysis in NOD mice has revealed several insulin-dependent diabetes (Idd) loci (Wicker et al., 1995) . Interestingly, gene(s) conferring susceptibility to diabetes in NOD mice (Ghosh et al., 1993) have been mapped to a region on chromosome 6 designated the natural-killer-gene complex (NKC) that contains a cluster of genes preferentially expressed by NK cells (Rogner et al., 2001; Yokoyama and Seaman, 1993) , including NKG2D (NKG2D is within the NKC (Ho et al., 1998) ). Thus, we examined NKG2D-dependent cytotoxicity and IFN-γ production in NOD mice and investigated whether the underlying NK cell abnormalities of NOD mice may involve the NKG2Ddependent activation pathway.
Results

Impaired NKG2D-dependent cytotoxicity and IFN-γ production in activated NOD NK cells
In this study, we compared NKG2D-dependent immune responses using IL-2 activated NK cells from NOD and NK1.1 congenic NOD (NK1.1 NOD) mice. Because Nkrp1 (NK1.1) is linked closely with NKG2D, the NKG2D gene in the NK1.1 congenic NOD mice is expected to be derived from the C57BL/6 strain (Carnaud et al., 2001) . NK cell-mediated cytotoxicity against YAC-1 target cells is primarily dependent upon NKG2D-dependent activation (Jamieson et al., 2002 and our publications) . Consistent with prior reports, cytotoxic activity of NOD NK cells against YAC-1 was significantly less than C57BL/6 NK cells ( Fig.1a ). Activated NK cells from NK1.1-congenic NOD mice also demonstrated less cytotoxicity against YAC-1 targets compared with the lytic activity of C57BL/6 NK cells. In addition, anti-NKG2D monoclonal antibody (a-NKG2D mAb) efficiently inhibited cytotoxicity against YAC-1 by NK cells from all strains of mice ( Fig. 1a ). To directly evaluate the function of NKG2D-mediated cytotoxicity, we analyzed the ability of activated C57BL/6 and NOD NK cells to kill Ba/F3 pro-B cells transfected with a NKG2D ligand, RAE-1γ (Cerwenka et al., 2000) . Only low levels of cytotoxicity were observed against BaF/3 mock transfectants using NK cells from all strains of mice. In contrast, the NKG2D-dependent cytotoxicity against RAE-1 transfectants was remarkably less using activated NK cells from NOD or NK1.1 NOD mice compared with C57BL/6 NK cells ( Fig.1b ). NKG2D-dependent cytotoxicity of these NK cells was completely abrogated by a-NKG2D mAb (Fig. 1b ). Thus, these findings suggest that a defect in the NKG2Ddependent activation pathway in NOD and NK1.1 NOD NK cells may be responsible for the diminished cytotoxicity against YAC-1 target cells. In addition, we found that NKG2D-dependent IFN-γ production, induced by cross linking with anti-NKG2D mAb, 5 was reduced using activated NK cells from NOD or NK1.1 NOD mice as compared with that produced by activated C57BL/6 NK cells (Fig. 1c ). These results indicated that NKG2D-dependent functions are decreased in activated NK1.1 NOD and NOD NK cells.
NKG2D expression on NOD NK cells
To explain the abnormal NKG2D function in NOD NK cells, we examined NKG2D expression on NK1.1 NOD, NOD and C57BL/6 NK cells. While low but comparable levels of NKG2D were observed on fresh NK cells from these strains (data not shown), NKG2D expression was dramatically decreased in activated NK cells from NOD and NK1.1 NOD mice as compared to C57BL/6 NK cells ( Fig. 2a ). The decrease in NKG2D expression on NOD NK cells was selective since the expression levels of CD44 and NK1.1 expression were equivalent to C57BL/6 NK cells ( Fig. 2a ). To determine whether the decrease in NKG2D surface expression was caused by transcriptional regulation, we measured mRNA expression of NKG2D and DAP10 in NK cells by real-time quantitative PCR. Prior studies have shown that expression of NKG2D on the cell surface requires its association with DAP10 (Wu et al., 1999) . As shown in Fig. 2b , NOD NK cells expressed equivalent of NKG2D and DAP10 mRNA compared to C57BL/6 NK cells, excluding differential transcription as the cause for diminished NKG2D expression on NOD NK cells.
An alternative possibility to account for the difference between NKG2D expression on NOD versus C57BL/6 NK cells was ligand-induced modulation of NKG2D in NOD NK cells. Unexpectedly, we found that activated NK cells from NOD and NK1.1 NOD mice expressed ligands for NKG2D whereas NKG2D ligands were undetectable on NK cells from C57BL/6 mice ( Fig.2c) . Moreover, the presence of RAE-1 in activated NOD NK cells, but not C57BL/6 NK cells, was confirmed by analyzing RAE-1 mRNA expression using real-time quantitative RT-PCR ( Fig. 2d ). Transcripts of RAE-1α, β, and γ and H-60 6 were detected in NOD activated NK cells. By contrast, transcripts for NKG2D ligands were not present in NK cells from C57BL/6 mice ( Fig. 2d ). In addition, activated NK cells from NOD and NK1.1 NOD mice stained positively with a mouse NKG2D-Ig fusion protein and this was confirmed using an anti-RAE-1 specific mAb ( Fig. 2e ). These results suggest that ligand-dependent modulation of NKG2D may account for the impairment in NKG2D-dependent function in NOD NK cells.
Ligand-induced NKG2D modulation
We investigated whether NKG2D is modulated by the interaction with its ligands. C57BL/6 NK cells were co-cultured with B16 melanoma cells transfected with RAE-1ε or mock transfectants. Although no difference was observed in CD44 expression, NKG2D expression on NK cells was dramatically decreased after co-culture with RAE-1ε bearing transfectants as compared to NK cells co-cultured with mock transfectants (Fig. 3a ) or NK cells cultured in the absence of target cells (data not shown). NK cells were harvested and assayed for cytolytic activity against YAC-1 targets. The diminished levels of NKG2D on NK cells co-cultured with RAE-1 transfectants correlated with the impaired cytolytic activity against YAC-1 (killing was ~40% less than that with NK cells co-cultured with mock transfectants) ( Fig. 3b ). Similar results were obtained using RAE-1 transfected cells as targets in cytotoxicity assays ( Fig. 3c ). In addition, NKG2D-dependent IFN-γ production was decreased substantially in NK cells previously co-cultured with RAE-1 transfectants as compared with NK cells co-cultured with mock transfectants (Fig. 3d ).
To examine whether NKG2D is also modulated on NK cells in vivo, we injected RAE-1γ transfected RMA cells or mock-transfected RMA cells into the spleen of C57BL/6 mice. After 5 days, splenocytes were harvested and analyzed by flow cytometry. Although no difference was observed in NK1.1 (data not shown) or CD44 expression on NK cells 7 from mice injected with RAE-1γ + RMA cells or mock RMA cells, the levels of NKG2D were substantially reduced on NK cells from mice injected with RAE-1 γ + RMA transfectants ( Fig. 3e ). Furthermore, we investigated whether NKG2D modulation was reversible. NK cells were co-cultured with irradiated RAE-1 ε + B16 or mock-transfected B16 cells and ligand-induced modulation of NKG2D was confirmed. NK cells were harvested and purified to remove residual tumor cells and then cultured in IL-2 only for 24 hr. In the absence of ligand, expression of NKG2D was restored to normal levels ( Fig. 3f ).
Therefore, NKG2D modulation was reversible. These results indicate that NKG2D modulation is caused by the interaction with NKG2D ligands, which in turn leads to a decrease in NKG2D-dependent cytotoxicity and IFN-γ production.
DAP10-mediated PI3 kinase activation augments ligand-induced NKG2D modulation
To further elucidate the mechanism of NKG2D modulation, we established an in vitro model using transfectants of Ba/F3 expressing mouse NKG2D and DAP10. Ba/F3 is a transformed pro-B cell line lacking NK cell function. This permits analysis of interactions of NKG2D with ligand in the absence of target cell killing or other potential pathways involved in NK cell activation. NKG2D+DAP10-Ba/F3 cells were co-cultured with RAE-1 γ transfected RMA (RMA -RAE-1 γ) cells or mock-transfected RMA cells. After 24 hrs, NKG2D expression on the Ba/F3 transfectants was modulated by co-culture with RAE-1 γtransfected RMA cells, but not mock-transfected RMA cells ( Fig. 4a ). To exclude the possibility that NKG2D was masked by the presence of RAE-1 protein that was shed from the RAE-1 transfectants, rather than due to ligand-induced receptor modulation, the NKG2D+DAP10-Ba/F3 cells co-cultured with RAE-1 γ + RMA were washed briefly in acidic buffer (pH 4.0) before staining with anti-NKG2D mAb. While washing with acidic buffer completely removed soluble NKG2D ligand (i.e. an H-60-Ig fusion protein 8 (Cerwenka et al., 2000) ) from NKG2D+DAP10-Ba/F3 transfectants (data not shown), this treatment did not reveal expression of NKG2D on the cells co-cultured overnight with RAE-1 γ + RMA cells (Fig. 4a ). Furthermore, the DAP10 protein expressed in the NKG2D transfectants had an N-terminal Flag epitope tag that also demonstrated down-regulation after ligand-induced modulation of NKG2D (data not shown). Together, these results indicated that the observed decreased levels of NKG2D were due to receptor modulation, rather than masking by soluble ligand.
To determine whether NKG2D was internalized after binding RAE-1, the NKG2D bearing cells after co-culture with RAE-1 transfectants were fixed, permeabilized and analyzed for the presence of intracytoplasmic NKG2D. While the amount of NKG2D on the cell surface was reduced on cells co-cultured with RAE-1 transfectants, no difference was observed in the total amount of NKG2D detected by staining of permeabilized cells, which permits detection of both surface and cytoplasmic antigen ( Fig.   4b ). Therefore, modulation of NKG2D may be caused by internalization. To determine whether degradation in lysosomes is involved in NKG2D down modulation, we treated NKG2D-DAP10 transfectants co-cultured with RAE-1 transfectants with the lysosome inhibitors, NH 4 Cl, or chloroquine. In the Ba/F3 transfectants, NKG2D modulation was not influenced by the lysosome inhibitors ( Fig. 4c ), suggesting that NKG2D down-modulation was independent of the lysosomal compartment. Endocytosis can be mediated by either clathrin-dependent or clathrin-independent mechanisms. Because clathrin-dependent endocytosis is inhibited by hypertonic conditions (Cefai et al., 1998; Rapoport et al., 1997; Sorkin and Carpenter, 1993) , we investigated whether this would affect NKG2D modulation. As shown Fig. 4d , NKG2D modulation was inhibited in hypertonic medium (0.45 M sucrose), suggesting that clathrin-dependent endocytosis may be involved in NKG2D modulation.
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Further studies were conducted to determine whether signaling is required for efficient ligand-induced modulation of NKG2D. DAP10 possesses a YxxM motif, which binds to the p85 subunit of PI3 kinase and Grb-2 (Chang et al., 1999; Wu et al., 1999) . In addition, it is possible that the clathrin adapter complex AP-1 and/or AP-2 will bind the YxxM motif (Brodsky et al., 2001) . We examined whether the YxxM motif of DAP10 binds to AP-2 clathrin adaptor complexes. However, we could not detect AP-2 association with DAP10 (data not shown). These findings prompted us to examine whether PI3 kinase activity is involved in NKG2D modulation. To this end, NKG2D -DAP10 Ba/F3 transfectants were co-cultured with RAE-1 transfectants in the presence of the PI3 kinase inhibitor, LY294002. In the presence of the PI3 kinase inhibitor, substantially less modulation of NKG2D was observed, compared to the amount of ligand-induced receptor modulation that was induced in the absence of the drug (Fig. 4e ). To further confirm the participation of DAP10 in receptor modulation, we generated Ba/F3 transfectants expressing NKG2D and a DAP 10 protein with a Y-F mutation in the YxxM motif (DAP10 Y-F mut-Ba/F3). The NKG2D -mutant DAP10 complex was expressed at a similar level as wild-type NKG2D -DAP10 in the Ba/F3 transfectants. Ligand-induced modulation of NKG2D was remarkably less efficient in transfectants expressing the mutant DAP10 compared with wild-type DAP10 ( Fig.4f ), suggesting that DAP10-mediated signal transduction is involved. However, partial NKG2D modulation was observed in the DAP10 mutant transfectant, similar to results obtained using the PI3 kinase inhibitor.
Discussion
In this study, we established that the impaired functions of NK cells in NOD mice are at least in part caused by NKG2D modulation on activated NK cells. Diminished NKG2D on activated NOD NK cells was secondary to ligand-induced internalization of the receptor.
Further studies determined that activation of PI3 kinase through the YxxM motif of DAP10 is involved in this process. In this regard, modulation of NKG2D on NK cells and CD28 on T cells is similar (Cefai et al., 1998) , but distinct from CTLA-4 modulation (Schneider et al., 1999) . While expression of CTLA-4 is regulated by AP-2 binding, we could not detect AP-2 binding to phosphorylated or non-phosphorylated DAP10, similar to what was reported previously for CD28 (Schneider et al., 1999) . However, modulation of NKG2D was inhibited in hypertonic medium, suggesting that endocytosis of NKG2D may utilize a clathrin coated-pit dependent pathway, similar to CD28 (Schneider et al., 1999) and epidermal growth factor receptor (Sorkin and Carpenter, 1993) .
A striking difference between NK cells from C57BL/6 and NOD mice was the finding that NK cell activation induced the RAE-1 ligands of NKG2D in NOD, but not C57BL/6 NK cells. Thus, in NOD mice both the NKG2D receptor and its ligands are expressed on the same NK cell, which may cause self-modulation of NKG2D expression and function. The difference between NK cells in NOD and C57BL/6 appears to be determined at the level of expression of RAE-1 and not the NKG2D receptor. Indeed, the nucleotide sequences of coding regions of NKG2D and DAP10 are identical in NOD and C57BL/6 mice (unpublished observation) and we show that these genes were transcribed in equal amounts in NOD and C57BL/6 NK cells. Furthermore, activated NK cells from NK1.1 congenic NOD mice, which have both the NK1.1 allele and the linked NKG2D locus from C57BL/6, demonstrated diminished NKG2D expression and function. It should be noted that the RAE-1 genes are not linked to NK1.1; therefore, the RAE-1 genes are of 11 NOD origin in the NK1.1 NOD congenic mice. When C57BL/6 NK cells were co-cultured with transfectants expressing RAE-1, NKG2D on the NK cells was modulated and NKG2D-dependent functions were impaired to an extent comparable to activated NOD NK cells. This phenotype was reversible, since NKG2D expression and function recovered when C57BL/6 NK cells were further cultured in the absence of ligand-bearing cells.
Consistent with our study, previous reports have demonstrated that NK cell cytotoxicity was decreased following exposure to target cells and the cytolytic activity was recovered following culture in the presence of activating cytokines (Abrams and Brahmi, 1988; Jewett and Bonavida, 1995; Perussia and Trinchieri, 1981; Timonen et al., 1979) It is noteworthy that the NKG2D ligands are remarkably different in C57BL/6 and NOD mice. NOD mice express RAE-1α, β, and γ and H-60, whereas C57BL/6 mice lack these ligands but instead express RAE-1δ and -ε (Cerwenka and Lanier, 2001) . As yet, little is know about the transcriptional regulation of RAE-1 gene expression, but our findings suggest that the RAE-1 genes in NOD are induced in NK cells by activation, whereas in C57BL/6 they are not.
Similarly, the ligands of NKG2D in humans (i.e. MICA, MICB, and ULBP) are polymorphic, whereas DAP10 and NKG2D in mice and human are monomorphic. It will be of interest to determine whether NKG2D expression and function in human NK cells is influenced by the induction of NKG2D ligands on NK cells in certain individuals. NKG2D-dependent cytotoxicity was also reduced in fresh NOD NK cells as compared with C57BL/6 NK cells (data not shown). However, the expression levels of NKG2D in fresh NOD and NK1.1NOD NK cells were similar to fresh C57BL/6 NK cells (data not shown). As reported previously, the NK cell abnormalities in NOD mice and IDDM patients may be due to multiple defects (Attallah et al., 1987; Poulton et al., 2001; Shultz et al., 1995) . Therefore, NK cell defects other than NKG2D modulation may be present in NOD mice.
We found that the interaction of RAE-1 and NKG2D on NK cells induced dysfunction of activated NK cells. In the case of NOD NK cells, this could be caused by modulation of NKG2D by ligand expression within the cytoplasm of the NK cells themselves, because NOD NK cells express both receptor and ligands. Interactions between C57BL/6 NK cells, which do not express NKG2D ligands, and tumors expressing RAE-1 resulted in modulation of receptor expression and function. This was demonstrated in vitro, but also was observed on NK cells isolated from the spleen (but not the liver) of mice that received an intrasplenic injection of a lymphoma transfected with RAE-1. These data indicated that NKG2D on NK cells was modulated by the interaction with RAE-1 in vivo in the local microenvironment. Initial interactions between NK cells and NKG2D ligand-bearing cells may trigger killing and cytokine production. However, prolonged exposure to ligands may de-sensitize NK cells rendering them functionally anergic. This has implications in the context of tumor development because secretion of soluble NKG2D ligands by tumors (Groh et al., 2002) or prolonged exposure of NK cells to ligand-bearing tumors may render them dysfunctional. This may contribute to tumor escape from NK cell and CD8 + T cell immune surveillance.
NKG2D may also play a role in autoimmunity. If NKG2D ligands are induced due to inflammation or perhaps inappropriately over-expressed in autoimmune-predisposed individuals, this may exacerbate the disease. In the case of IDDM, perhaps over-expression of NKG2D ligands in the pancreas of certain predisposed individuals may co-stimulate autoreactive CD8 + T cells, thereby inducing or augmenting the disease. In preliminary studies, we have detected transcription of RAE-1 genes in the pancreas of diseased NOD mice, but not young, healthy mice. Of particular interest is the remarkable polymorphism of the genes encoding the NKG2D ligands in mice and human (e.g. more than 50 alleles of human MICA have been identified). Polymorphisms of human MICA have been 13 associated with a variety of autoimmune disorders, including type I diabetes, ulcerative colitis, primary sclerosing cholangitis, familial Mediterranean fever, and Behcet's disease (Mizuki et al., 1997; Norris et al., 2001; Sugimura et al., 2001; Touitou et al., 2001; Wallace et al., 1999) . Whether expression of NKG2D ligands is involved in the induction of disease or only results as a consequence of inflammation is unknown. Nonetheless, our findings suggest that the NKG2D pathway should be considered in autoimmune disease, as well as cancer.
Experimental Procedures
Mice
Six to eight week-old C57BL/6 mice were purchased from Charles River, (Wilmington, MA). NOD mice were obtained from Taconic (Germantown, NY). NK1.1-congenic NOD mice were generated as described previously (Carnaud et al., 2001) . Experiments were performed using gender and age-matched mice. All mice were maintained under specific pathogen-free conditions in the animal facility of the University of California, San Francisco (UCSF). All experiments were performed according to the guidelines of the UCSF Committee on Animal Research.
Reagents, cytokines and antibodies
Human recombinant Interleukin (IL)-2 was generously provided by the NCI BRB Preclinical Repository. Mouse recombinant IL-12 was kindly provided by Dr. J.P.
Houchins (R&D Systems, Minneapolis, MN). The PI3 kinase inhibitor, LY294002 was purchased from CALBIOCHEM (La Jolla, CA). Anti-mouse NKG2D monoclonal antibody CX5 (rat IgG2a isotype) was generated by immunizing rats with purified protein of mouse NKG2D kindly provided from Dr. Chris O' Callaghan (CIT). The antibody recognizes the NKG2D extracellular domain and efficiently blocks the binding of NKG2D to its ligands. Anti-mouse RAE-1 monoclonal antibody CX1 (rat IgG2b isotype) was generated by immunizing rats with CHO cells stably transfected with mouse RAE-1γ. CX1 mAb binds strongly to RAE-1γ and weakly to RAE-1α and RAE-1β, but does not react with RAE-1δ or RAE-1ε. Binding of RAE-1 to NKG2D is blocked in the presence of CX1 mAb.
Cytokine production
15 NK cells (2x10 5 ) were placed in RPMI-1640 containing 10% FCS and IL-2 (2000 U/ml), and were cultured for 18 hrs in plates precoated with the immobilized antibodies, as described previously (Ogasawara et al., 2002) . To block Fc receptor-dependent activation, NK cells were pretreated with soluble anti-CD16/32 mAb 2.4G2 (BD PharMingen, San Diego, CA) (10 µg/ml) for 30 min. The amount of IFN-γ in the culture supernatants was determined with a mouse IFN-γ-specific ELISA kit (OptEIA mouse IFN-γ set), purchased from BD PharMingen (San Diego, CA) and used according to the manufacturer's instructions. Statistical analysis was performed by using a two-sample t-test.
Cell lines, plasmids, and transfectants
For sequence analysis, mouse DAP10 and NKG2D were amplified from cDNA prepared (Kinsella and Nolan, 1996; Onihsi et al., 1996) . RMA cells were transduced by using retroviruses generated with the pMX-puro vector (Kinsella and Nolan, 1996; Onihsi et al., 1996) . Other stable transfectants were established by using retroviruses generated with the pMX-pie vector. The murine NKG2D cDNA was cloned by PCR using oligonucleotide primers (Sense 5'GAGCAAATGCCATAATTACGACC -3', Anti-sense 5'-ACCGCCCTTTTCATGCAGATG-3'), and the cDNA was ligated into the pMX-pie vector. The Y residue in the cytoplasmic domain of Flag-human DAP10 (Wu et al., 2000) was mutated to F by standard PCR mutagenesis and these cDNA were ligated into pMX-neo vectors. This construct was transfected into Phoenix-A packaging cells (generously provided by Dr. Garry Nolan, Stanford) by using Lipofectamine 2000 (Gibco BRL) (Kinsella and Nolan, 1996; Onihsi et al., 1996) . Two days later, the supernatants containing viruses were collected and used to infect 5 x 10 4 Ba/F3, and RMA cells in the presence of polybrene (8 µg/ml).
Preparation of NK cells
NK cells were prepared as described previously (Ogasawara et al., 2002) . Briefly, spleen cells were incubated with anti-CD4 mAb (clone GK1.5) and anti-CD8 mAb (clone 53-6.7), and thereafter these cells were mixed with magnetic beads coated with goat anti-mouse immunoglobulin (Ig) Ab and goat anti-rat Ig Ab (Advanced Magnetic, Inc, Cambridge, MA). CD4, CD8, and surface Ig (sIg) positive cells were removed by magnetic cell sorting. The CD4-, CD8-and Ig-depleted splenocytes were stained with a PE-conjugated pan-NK cell mAb DX5 (BD PharMingen, San Diego, CA), followed by incubation with magnetic microbeads coated with anti-PE-Ab (Miltenyi Biotec Inc., Germany). Thereafter, DX5 + cells were isolated by magnetic cell sorting using a MACS (Miltenyi Biotec Inc., Germany). The purity of the DX5 + cells was more than 95%, as determined by flow cytometric analysis. The yield of purified NK cells per spleen from the different mouse strains was as follows: C57BL/6 (number x10 -6 =1.36 ± 0.13), NK1.1NOD (number x10 -5 =8.17 ± 0.23), NOD (number x10 -5 =6.14 ± 0.15). The purified NK cells were cultured in RPMI-1640 supplemented with 10% FCS and 5 x 10 -5 M 2-mercaptoethanol in the presence of 4000 U/ml human recombinant IL-2, for 3-5 days.
Flow cytometric analysis
Cells were incubated with biotinylated anti-NKG2D mAb, biotinylated isotype control Ig (cIg) or biotinylated anti-RAE-1γ mAb and then PE-streptavidin and anti-NK1.1-FITC or anti-DX5-FITC (BD PharMingen, San Diego, CA). To detect NKG2D ligands, we used the extracellular domain of mouse NKG2D fused to human IgG1 Fc (mNKG2D-Ig) (Cerwenka et al., 2000) . A PE-conjugated goat anti-human IgG Fcγ fragment (Jackson ImmunoResearch, West Grove, PA) was used as a second step reagent. The cells (1 x 10 6 ) were stained with 0.5 µg of mNKG2D-Ig and with 0.25 µg of other mAbs. The incubation was carried out for 20 min, after which the cells were washed with PBS containing 0.01% NaN 3 . Cells were analyzed by using a FACSCalibur (Becton Dickinson, San Jose, CA) or a small desktop Guava® Personal Cytometer with Guava ViaCount™ and Guava Express™ software (Burlingame, CA). Viable lymphocyte populations were gated based on forward and side scatters and by propidium iodide staining.
Cytotoxic Assay
Target cells were labeled with 50 µCi of Na 2 ( 51 Cr) O 4 for 60 min at 37 o C in RPMI-1640 medium containing 10 % FCS, washed three times with medium, and used in cytotoxicity assays. 51 Cr-labeled target cells (5 x 10 3 ) and effector cells were mixed in U-bottomed wells of a 96-well microtiter plate at the indicated E/T ratios in triplicate. After a 4-hr incubation, the cell-free supernatants were collected and the radioactivity was measured in a Micro-beta counter (Wallac, Turku, Finland). The spontaneous release was less than 15% of the maximum release. The percentage of specific 51 Cr release was calculated according to the following formula: %Specific lysis =(experimentalspontaneous) release x 100 / (maximalspontaneous) release.
A lytic unit (LU 40 ) was defined as the number of effector cells required to achieve 40% specific release. It was deduced from the mathematical slope of the line generated by plotting percent lysis vs. effector to target cell ratio. Lytic units per 10 6 NK cells were determined by dividing lytic units per 10 6 cells.
Quantitative PCR
Quantitative ( The anti-NKG2D mAb (squares) or the cIg (circles) was present throughout the cytotoxic assay. Cytotoxicity was measured by 51 Cr release after 4 hr. Lytic unit (LU 40 ) against YAC-1 targets were as follows: C57BL/6 (LU 40 =1.17x10 6 ), NK1.1NOD (LU 40 =7.61x10 4 ) and NOD (LU 40 =6.47x10 4 ). b. NKG2D-dependent cytotoxicity mediated by NK1.1 NOD and NOD NK cells. NK cells were purified and activated with IL-2 as in Fig. 1a .
Cytotoxic activity against RAE-1γ transfected Ba/F3 cells and mock Ba/F3 transfectants was tested by using a 4-h 51 Cr release assay. Data are represented as the mean % cytotoxicity ± SD (triplicates). Similar results were obtained in two independent experiments. c. NKG2D-dependent IFN-γ production by NK1.1 NOD and NOD NK cells.
NK cells were stimulated with immobilized mAb (1 µg ml -1 ) or IL-12 1 ng ml -1 for 18 hr.
Conditions were as follows: anti-NKG2D mAb (filled column), rat cIg (open column), anti-NK1.1 mAb (hatched column) and IL-12 (gray column). Culture supernatants were collected for the measurement of IFN-γ by ELISA. Differences in IFN-γ production of NK cells from C57BL/6, NOD and NK1.1 NOD induced by anti-NKG2D mAb stimulation were highly significant, * P<0.01; C57BL/6 versus NK1.1 NOD, P<0.01; C57BL/6 versus NOD. representative data are shown. Anti-RAE-1 mAb CX1 predominantly reacts with RAE-1γ, but also reacts weakly with RAE-1α and RAE-1β, but not H-60. represented as the mean % cytotoxicity ± SD (triplicates). Similar results were obtained in two independent experiments. d. IFN-γ production induced by cross-linking with anti-NKG2D mAb was reduced in NK cells previously co-cultured with RAE-1 + B16 transfectants. NK cells co-cultured with mock or RAE-1 B16 transfectants were harvested, purified from the residual tumor cells and then were stimulated with immobilized mAb (3µg ml -1 ) for 18 hr. Culture supernatants were collected for measurement of IFN-γ by ELISA. The amount of IFN-γ produced by NK cells cultured with the plated coated with control rat IgG (open column), anti-NKG2D mAb (filled column), or anti-NK1.1 mAb intracellular NKG2D after modulation. Ba/F3 NKG2D-DAP10 cells were co-cultured with RMA or RMA RAE-1γ cells for 14 hrs. After co-culture, cells were fixed in 1% paraformaldehyde and permeabilized by saponin. Then, these cells were stained with a-NKG2D mAb. (Note that the staining intensity of anti-NKG2D mAb was less on fixed cells, compared with fresh cells, probably because fixation affected the antigen.) c. 
